Is a complete HEL/HRTIS research report available?

No complete published report is available for hel/HRTIS (HEL/HRTIS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

HEL/HRTIS (HEL/HRTIS)

Nasdaq Helsinki: HEL/HRTIS · EUR

€1.56

+0.02 (+1.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-08-02 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first HEL/HRTIS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	41.3M
Net income (ttm)	-6.6M
EPS (ttm)	-€0.28
Shares out	26.5M
Volume	25,887
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -6.6M
EPS (ttm): -€0.28
Market cap: 41.3M

All HEL/HRTIS indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

EUR

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Employees	13
Employees Change	2%
Employees Change Percent	18.18
Enterprise value	EUR 38.8M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FI4000087861
Last refreshed	2026-08-02
Market cap	EUR 41.3M
Price	EUR 1.56
Price currency	EUR
Sector	Healthcare
Sector PE	21.97
Sector PE Fwd	18.66
Sic	2834
Symbol	hel/HRTIS
Website	https://herantis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.01%
FCF yield	-14.74%
P/B ratio	-24.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -6.6M
Net Income Growth Years	0%
Profit Per Employee	EUR -509,242
ROA	-152.6
Roa5y	-70.87
ROCE	-364.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.61%
Cagr1y	-11.87%
Cagr3y	-0.32%
Cagr5y	-9.42%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 2.7M
Cash	EUR 2.6M
Current Assets	EUR 2.7M
Current Liabilities	EUR 912,993
Debt	EUR 69,182
Debt FCF	EUR -0.01
Equity	EUR -1.7M
Interest Coverage	-465.3
Liabilities	EUR 4.4M
Long Term Assets	EUR 0
Long Term Liabilities	EUR 3.4M
Net Cash	EUR 2.5M
Net Cash By Market Cap	EUR 6.11
Net Cash Growth	20.1%
Tangible Book Value	EUR -1.7M
Tangible Book Value Per Share	EUR -0.07
WACC	7.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.92
Net Working Capital	EUR -792,173
Quick ratio	2.88
Working Capital	EUR 1.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	72.66%
1Y total return	-11.86%
200-day SMA	1.99
3Y total return	-0.95%
50-day SMA	1.81
50-day SMA vs 200-day SMA	50under200
5Y total return	-39.02%
All Time High	11
All Time High Change	-85.82%
All Time High Date	2014-06-11
All Time Low	0.77
All Time Low Change	103.92%
All Time Low Date	2016-07-18
ATR	0.1
Beta	0.6
Beta1y	0.88
Beta2y	0.16
Ch YTD	-23.53
High	1.63
High52	3.87
High52 Date	2025-10-08
High52ch	-59.69%
Low	1.51
Low52	1.51
Low52 Date	2026-07-31
Low52ch	2.63%
Ma50ch	-14%
Price vs 200-day SMA	-21.45%
RSI	34.53
RSI Monthly	45.37
RSI Weekly	38.75
Sharpe ratio	0.09x
Sortino ratio	0.24
Total Return	-17.23%
Tr YTD	-23.53
Tr1m	-15.22%
Tr1w	-2.86%
Tr3m	-11.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -6.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,671,208%
Net Borrowing	1,262,595
Shares Insiders	14.44%
Shares Institutions	39.4%
Shares Out	26,503,817
Shares Qo Q	-3.82%
Shares Yo Y	17.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	18,136.4x
Bv Per Share	-0.07
Ch10y	64.21
Ch1m	-15.22
Ch1w	-2.86
Ch1y	-11.86
Ch3m	-11.16
Ch3y	-0.95
Ch5y	-42.01
Ch6m	-33.33
Change	1.3%
Change From Open	1.3
Close	1.54
Days Gap	0
Dollar Volume	40,383.7
Earnings Date	2026-08-20
EBIT	EUR -6.4M
EPS	EUR -0.28
F Score	2
FCF	EUR -6.1M
FCF EV Yield	-15.7x
FCF Per Share	EUR -0.23
Financing CF	6,455,585
Fiscal Year End	December
Founded	2,008
Investing CF	-243,782
Is Primary Listing	1
Last Earnings Date	2026-03-05
Last Report Date	2025-12-31
Ma150	1.93
Ma150ch	-19.21%
Ma20	1.68
Ma20ch	-7.09%
Net CF	116,478
Next Earnings Date	2026-08-20
Open	1.54
Position In Range	42.86
Price Date	2026-07-31
Relative Volume	1.53x
Tr6m	-33.33%
Volume	25,887

HEL/HRTIS (HEL/HRTIS)

Coverage state: Market snapshot only — no published research

Generate the first HEL/HRTIS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · HEL/HRTIS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HEL/HRTIS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HEL/HRTIS

Frequently asked questions